The University of Texas at San Antonio (UTSA) and GenCure are working together on the development of cellular therapy products and services under a new master services agreement. GenCure will provide UTSA with research starting materials, and UTSA will offer testing services for materials produced by GenCure. The collaboration aims to boost the clinical application of stem cell therapeutics.
How can regulators prevent cyberattacks like Change Healthcare? : Shots
The US healthcare system remains vulnerable to cyberattacks, with a cautionary tale being the ransomware attack on payments manager Change Healthcare in February 2021. Consequently,
